scholarly journals The Essential Role of Single Ig IL-1 Receptor-Related Molecule/Toll IL-1R8 in Regulation of Th2 Immune Response

2009 ◽  
Vol 182 (5) ◽  
pp. 2601-2609 ◽  
Author(s):  
Katarzyna Bulek ◽  
Shadi Swaidani ◽  
Jinzhong Qin ◽  
Yi Lu ◽  
Muhammet F. Gulen ◽  
...  
2007 ◽  
Vol 179 (6) ◽  
pp. 3821-3830 ◽  
Author(s):  
Qian Liu ◽  
Zhugong Liu ◽  
Cristina T. Rozo ◽  
Hossein A. Hamed ◽  
Farhang Alem ◽  
...  

2001 ◽  
Vol 120 (5) ◽  
pp. A67
Author(s):  
Dulciene M.M. Queiroz ◽  
Sarah M.S. Cinque ◽  
Gifone A. Rocha ◽  
Taciana F. Soares ◽  
Ana M.M.F. Nogueira ◽  
...  

2001 ◽  
Vol 120 (5) ◽  
pp. A67-A67
Author(s):  
D QUEIROZ ◽  
S CINQUE ◽  
G ROCHA ◽  
T SOARES ◽  
A NOGUEIRA ◽  
...  

2020 ◽  
Vol 2020 ◽  
pp. 1-9
Author(s):  
Xiang-Tian Meng ◽  
Yun-Yue Shi ◽  
Hong Zhang ◽  
Hong-Yan Zhou

Allergic conjunctivitis (AC) is a common allergic disease that is often associated with the onset of rhinitis or asthma. The incidence of AC has increased significantly in recent years possibly due to air pollution and climate warming. AC seriously affects patients’ quality of life and work efficiency. Th (T-helper) 2 immune responses and type I hypersensitivity reactions are generally considered the basis of occurrence of AC. It has been found that new subpopulations of T-helper cells, Th17 cells that produce interleukin-17 (IL-17), play an important role in the Th2-mediated pathogenesis of conjunctivitis. Studies have shown that Th17 cells are involved in a variety of immune inflammation, including psoriasis, rheumatoid arthritis, inflammatory bowel disease, systemic lupus erythematosus, and asthma. However, the role of Th17 and IL-17 in AC is unclear. This paper will focus on how T-helper 17 cells and interleukin-17 are activated in the Th2 immune response of allergic conjunctivitis and how they promote the Th2 immune response of AC.


2020 ◽  
Vol 205 (12) ◽  
pp. 3333-3347
Author(s):  
Parna Bhattacharya ◽  
Ranadhir Dey ◽  
Ankit Saxena ◽  
Subir Karmakar ◽  
Nevien Ismail ◽  
...  

2015 ◽  
Vol 156 (51) ◽  
pp. 2070-2076
Author(s):  
Barna Vásárhelyi ◽  
Katalin Mészáros ◽  
Gellért Karvaly ◽  
Attila Patócs

Estrogens modulate the immune response as well as the risk and progression of autoimmune disorders. Their effects are mediated by nuclear receptors (i.e. estrogen receptor alpha and beta), membrane receptors, and are influenced by their interactions with other hormones. Locally produced hormones and cytokines are the main factors in maintaining tissue homeostasis. The response of immune cells to estrogens is related to their developmental stage. The diverse effects of estrogens on various autoimmune disorders are the result of the versatility of their pathomechanism. In general, progression of B-cell mediated disorders is aggravated by estrogens. Their effects on T-cell mediated disorders, on the other hand, are driven by Th1 or Th2 dominance. As estrogens promote the escalation of the Th2 immune response, Th2-dominant disorders are aggravated, while Th1-dominant disorders are ameliorated upon high estrogen levels. Inflammation on its own also modulates the impact of estrogens. Inflammatory cytokines alter the expression of the alpha and beta estrogen receptors as well as the activity of estrogen metabolizing enzymes. Monitoring the local, tissue-wide interaction between hormones and immune cells would provide a better tool for identification and characterization of molecules involved in this system. To date, routinely used laboratory methods have a limited role in monitoring the local effects of estrogens. In this current paper the authors summarize the role of estrogens in immune system and overview those novel methods which are useful in the investigation of local endocrine milieu. Orv. Hetil., 2015, 156(51), 2070–2076.


Sign in / Sign up

Export Citation Format

Share Document